ESG: from reporting obligation to opportunity for value creation

Insights from Holland Capital and Deloitte’s webinar

Amsterdam,  21st of March 2025 –  On March 6, in partnership with Deloitte, we organized an engaging and inspiring ESG webinar for our portfolio companies. During the session, we explored the impact of ESG by discussing both regulations and, more importantly, opportunities for value creation. Deloitte shared valuable insights on how companies should approach ESG not just as a compliance issue, but rather as a possibility for growth and value creation.

More and more companies are facing ESG (Environmental, Social & Governance) reporting requirements. What could feel like an obligation actually offers opportunities for innovation and value creation. During the recent ESG webinar, organized by Holland Capital in collaboration with Deloitte, participating portfolio companies gained valuable insights into ESG and its impact on their organization. Below we share the key learnings from this webinar.

ESG: Why is it relevant?

ESG is not a trend, but has long been an essential aspect of how companies operate. Finding the right balance between a company’s impact on people, the environment and its (financial) performance is something the United Nations already pointed out 40 years ago. Companies should see sustainability not only as an obligation to comply with regulations, but also as an opportunity to become more efficient, transparent and future-proof.

  • Environmental: How does your company affect the environment? Consider carbon emissions, energy consumption and circular economy.
  • Social (social): How do you interact with employees, customers and society? Think diversity, inclusion and working conditions.
  • Governance (governance): How are policy and strategy set up to conduct business ethically?

A key message from the webinar: ESG is not only relevant for large corporates, but also for SMEs. Many companies are already implementing sustainable strategies and activities, perhaps without being aware of it being labeled as sustainable. By giving this structure, entrepreneurs can leverage ESG as a competitive advantage.

Laws and regulations: What do you need to know?

An important topic discussed during the webinar was the Corporate Sustainability Reporting Directive (CSRD). A brief update on the recently proposed changes:

  • Companies with more than 1,000 employees will not fall under the obligation until later.
  • Large companies continue to impose ESG reporting requirements on their suppliers and supply chain partners.
  • Transparency about ESG performance is becoming increasingly important to various stakeholders, such as banks, investors and potential employees.

    For entrepreneurs, this means that even if their company is  not (or no longer) directly in scope of the  the CSRD, they could indirectly be requested to share ESG information with partners and investors. This also applies to Holland Capital: our obligations towards investors and from complying with the Sustainable Finance Disclosure Regulation (SFDR) requires our portfolio companies to provide ESG data. Those insights can be valuable and provide benefits, or identify necessary actions.

Materiality: Where do you start? 

An important concept within ESG is materiality – or, in other words, which ESG topics are most relevant to your company? Materiality can be viewed from two perspectives, so-called double materiality:

  • Financial impact: Which ESG topics affect profitability?
  • Social impact: What impact does your company have on people and the environment?
  • A structured approach helps companies not only comply with regulations, but also achieve strategic benefits.

Conclusion: ESG as a catalyst for growth? 

The main message from the webinar: don’t see ESG as a burden, but as an opportunity for growth, efficiency and value creation. By understanding key material themes and responding to sustainability developments, companies can not only comply with regulations, but also gain strategic advantages.

Moreover, many companies are already engaged in sustainable initiatives and strategies – they might haven’t yet labeled them as ESG.

Xilloc raises growth financing from Holland Capital

Xilloc raises growth financing from Holland Capital Geleen/Amsterdam, July 2nd 2021 - Xilloc, a leading innovator and producer of medical implants and devices, has raised growth finance for its international expansion and product development from Holland Capital....

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Xilloc haalt groeifinanciering op bij investeerder Holland Capital Geleen/Amsterdam, 2 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is...

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Xilloc haalt groeifinanciering op bij investeerder Holland Capital Geleen/Amsterdam, 2 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is...

Yes We Can Healthcare Group joins forces with Holland Capital

Yes We Can Healthcare Group joins forces with Holland Capital Hilvarenbeek / Amsterdam, 1st of July 2021 – Holland Capital joins forces with Yes We Can Healthcare Group (YWCHG), a mental healthcare clinic for young people between 13 and 23 with addictions and...

Yes We Can Healthcare Group bundelt krachten met Holland Capital

Yes We Can Healthcare Group bundelt krachten met Holland Capital Hilvarenbeek/Amsterdam, 1 juli 2021 – Holland Capital bundelt krachten met Yes We Can Healthcare Group (YWCHG),  een jeugdkliniek voor jongeren van 13-23 jaar met psychische problemen, verslavingen en...

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Geleen/Amsterdam, 1 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is gespecialiseerd in het ontwerpen, produceren  en vermarkten vanmedische,...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl